Similarly, the levels of the hepatokine sex-hormone-binding globulin (SHBG), binding specifically estrogens and androgens, are lower in patients with metabolic syndrome [92], and circulating levels of SHBG are considered to be a biomarker for insulin resistance T2D [93]. This evidence concerns the gene SHBG and metabolic syndrome.